SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-184028
Filing Date
2015-05-12
Accepted
2015-05-12 16:30:00
Documents
8
Period of Report
2015-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d923806d8k.htm 8-K 38395
2 EX-3.1 d923806dex31.htm EX-3.1 132187
3 EX-4.1 d923806dex41.htm EX-4.1 31247
4 EX-10.1 d923806dex101.htm EX-10.1 211844
5 EX-10.2 d923806dex102.htm EX-10.2 48696
6 EX-10.3 d923806dex103.htm EX-10.3 77163
7 EX-10.4 d923806dex104.htm EX-10.4 29943
8 EX-10.5 d923806dex105.htm EX-10.5 74249
  Complete submission text file 0001193125-15-184028.txt   645213
Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33827 | Film No.: 15854804
SIC: 2835 In Vitro & In Vivo Diagnostic Substances